nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Dactinomycin—kidney cancer	0.248	1	CbGbCtD
Cefadroxil—SLC22A8—nephron—kidney cancer	0.0267	0.182	CbGeAlD
Cefadroxil—SLC22A8—urine—kidney cancer	0.0214	0.146	CbGeAlD
Cefadroxil—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.0137	1	CbGdCrCtD
Cefadroxil—SLC22A6—nephron tubule—kidney cancer	0.00961	0.0655	CbGeAlD
Cefadroxil—SLC22A6—cortex of kidney—kidney cancer	0.00823	0.0561	CbGeAlD
Cefadroxil—SLC15A1—nephron tubule—kidney cancer	0.008	0.0545	CbGeAlD
Cefadroxil—SLC15A1—renal system—kidney cancer	0.00727	0.0496	CbGeAlD
Cefadroxil—SLC15A1—kidney—kidney cancer	0.00703	0.0479	CbGeAlD
Cefadroxil—SLC22A8—nephron tubule—kidney cancer	0.00576	0.0392	CbGeAlD
Cefadroxil—SLC22A8—renal system—kidney cancer	0.00523	0.0356	CbGeAlD
Cefadroxil—SLC22A8—kidney—kidney cancer	0.00506	0.0345	CbGeAlD
Cefadroxil—SLC15A2—nephron tubule—kidney cancer	0.005	0.0341	CbGeAlD
Cefadroxil—SLC22A8—cortex of kidney—kidney cancer	0.00493	0.0336	CbGeAlD
Cefadroxil—SLC15A2—renal system—kidney cancer	0.00455	0.031	CbGeAlD
Cefadroxil—SLC15A2—kidney—kidney cancer	0.0044	0.0299	CbGeAlD
Cefadroxil—SLC22A5—nephron tubule—kidney cancer	0.00435	0.0296	CbGeAlD
Cefadroxil—SLC15A2—cortex of kidney—kidney cancer	0.00428	0.0292	CbGeAlD
Cefadroxil—SLC22A5—renal system—kidney cancer	0.00396	0.0269	CbGeAlD
Cefadroxil—SLC22A5—kidney—kidney cancer	0.00382	0.026	CbGeAlD
Cefadroxil—SLC22A5—cortex of kidney—kidney cancer	0.00372	0.0254	CbGeAlD
Cefadroxil—SLC22A5—cardiac atrium—kidney cancer	0.00354	0.0241	CbGeAlD
Cefadroxil—Arthralgia—Sorafenib—kidney cancer	0.0012	0.00203	CcSEcCtD
Cefadroxil—Pruritus—Pazopanib—kidney cancer	0.00119	0.002	CcSEcCtD
Cefadroxil—Erythema multiforme—Gemcitabine—kidney cancer	0.00118	0.002	CcSEcCtD
Cefadroxil—Somnolence—Everolimus—kidney cancer	0.00118	0.00199	CcSEcCtD
Cefadroxil—Dizziness—Temsirolimus—kidney cancer	0.00118	0.00199	CcSEcCtD
Cefadroxil—Convulsion—Sunitinib—kidney cancer	0.00117	0.00198	CcSEcCtD
Cefadroxil—Dyspepsia—Everolimus—kidney cancer	0.00117	0.00197	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—kidney cancer	0.00116	0.00197	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00116	0.00197	CcSEcCtD
Cefadroxil—Blood creatinine increased—Capecitabine—kidney cancer	0.00116	0.00196	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—kidney cancer	0.00116	0.00196	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00115	0.00195	CcSEcCtD
Cefadroxil—Arthralgia—Sunitinib—kidney cancer	0.00115	0.00195	CcSEcCtD
Cefadroxil—Anaphylactic shock—Sorafenib—kidney cancer	0.00115	0.00194	CcSEcCtD
Cefadroxil—Diarrhoea—Pazopanib—kidney cancer	0.00115	0.00194	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Everolimus—kidney cancer	0.00114	0.00193	CcSEcCtD
Cefadroxil—Vomiting—Temsirolimus—kidney cancer	0.00113	0.00191	CcSEcCtD
Cefadroxil—Thrombocytopenia—Sorafenib—kidney cancer	0.00112	0.0019	CcSEcCtD
Cefadroxil—Dyspepsia—Erlotinib—kidney cancer	0.00112	0.0019	CcSEcCtD
Cefadroxil—Rash—Temsirolimus—kidney cancer	0.00112	0.0019	CcSEcCtD
Cefadroxil—Dermatitis—Temsirolimus—kidney cancer	0.00112	0.00189	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00112	0.00189	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.00112	0.00189	CcSEcCtD
Cefadroxil—Headache—Temsirolimus—kidney cancer	0.00111	0.00188	CcSEcCtD
Cefadroxil—Dizziness—Pazopanib—kidney cancer	0.00111	0.00187	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Erlotinib—kidney cancer	0.0011	0.00186	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—kidney cancer	0.0011	0.00186	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—kidney cancer	0.0011	0.00186	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.00109	0.00185	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Vinblastine—kidney cancer	0.00109	0.00184	CcSEcCtD
Cefadroxil—Thrombocytopenia—Sunitinib—kidney cancer	0.00108	0.00183	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Everolimus—kidney cancer	0.00108	0.00183	CcSEcCtD
Cefadroxil—Vomiting—Pazopanib—kidney cancer	0.00107	0.0018	CcSEcCtD
Cefadroxil—Rash—Pazopanib—kidney cancer	0.00106	0.00179	CcSEcCtD
Cefadroxil—Nausea—Temsirolimus—kidney cancer	0.00106	0.00179	CcSEcCtD
Cefadroxil—Dermatitis—Pazopanib—kidney cancer	0.00106	0.00178	CcSEcCtD
Cefadroxil—Haemoglobin—Paclitaxel—kidney cancer	0.00105	0.00178	CcSEcCtD
Cefadroxil—Abdominal pain—Vinblastine—kidney cancer	0.00105	0.00178	CcSEcCtD
Cefadroxil—Headache—Pazopanib—kidney cancer	0.00105	0.00178	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00105	0.00177	CcSEcCtD
Cefadroxil—Abdominal pain—Everolimus—kidney cancer	0.00105	0.00177	CcSEcCtD
Cefadroxil—Body temperature increased—Everolimus—kidney cancer	0.00105	0.00177	CcSEcCtD
Cefadroxil—Haemorrhage—Paclitaxel—kidney cancer	0.00105	0.00177	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Erlotinib—kidney cancer	0.00104	0.00177	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—kidney cancer	0.00104	0.00176	CcSEcCtD
Cefadroxil—Vaginal infection—Doxorubicin—kidney cancer	0.00104	0.00176	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—kidney cancer	0.00103	0.00175	CcSEcCtD
Cefadroxil—Vertigo—Vincristine—kidney cancer	0.00103	0.00174	CcSEcCtD
Cefadroxil—Thrombocytopenia—Dactinomycin—kidney cancer	0.00102	0.00173	CcSEcCtD
Cefadroxil—Pancytopenia—Capecitabine—kidney cancer	0.00102	0.00172	CcSEcCtD
Cefadroxil—Dyspepsia—Sorafenib—kidney cancer	0.00101	0.00171	CcSEcCtD
Cefadroxil—Abdominal pain—Erlotinib—kidney cancer	0.00101	0.00171	CcSEcCtD
Cefadroxil—Body temperature increased—Erlotinib—kidney cancer	0.00101	0.00171	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00101	0.0017	CcSEcCtD
Cefadroxil—Neutropenia—Capecitabine—kidney cancer	0.001	0.00169	CcSEcCtD
Cefadroxil—Nausea—Pazopanib—kidney cancer	0.000996	0.00168	CcSEcCtD
Cefadroxil—Convulsion—Vincristine—kidney cancer	0.000993	0.00168	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000992	0.00168	CcSEcCtD
Cefadroxil—Erythema multiforme—Paclitaxel—kidney cancer	0.000988	0.00167	CcSEcCtD
Cefadroxil—Hypersensitivity—Vinblastine—kidney cancer	0.000979	0.00165	CcSEcCtD
Cefadroxil—Hypersensitivity—Everolimus—kidney cancer	0.000975	0.00165	CcSEcCtD
Cefadroxil—Dyspepsia—Sunitinib—kidney cancer	0.000973	0.00164	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000954	0.00161	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000953	0.00161	CcSEcCtD
Cefadroxil—Asthenia—Vinblastine—kidney cancer	0.000953	0.00161	CcSEcCtD
Cefadroxil—Asthenia—Everolimus—kidney cancer	0.00095	0.00161	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000947	0.0016	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Sorafenib—kidney cancer	0.000939	0.00159	CcSEcCtD
Cefadroxil—Pruritus—Everolimus—kidney cancer	0.000936	0.00158	CcSEcCtD
Cefadroxil—Anaphylactic shock—Vincristine—kidney cancer	0.000935	0.00158	CcSEcCtD
Cefadroxil—Arthralgia—Gemcitabine—kidney cancer	0.000925	0.00156	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000919	0.00155	CcSEcCtD
Cefadroxil—Asthenia—Erlotinib—kidney cancer	0.000916	0.00155	CcSEcCtD
Cefadroxil—Thrombocytopenia—Vincristine—kidney cancer	0.000915	0.00155	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000915	0.00155	CcSEcCtD
Cefadroxil—Urticaria—Sorafenib—kidney cancer	0.000913	0.00154	CcSEcCtD
Cefadroxil—Diarrhoea—Vinblastine—kidney cancer	0.000909	0.00154	CcSEcCtD
Cefadroxil—Body temperature increased—Sorafenib—kidney cancer	0.000908	0.00154	CcSEcCtD
Cefadroxil—Abdominal pain—Sorafenib—kidney cancer	0.000908	0.00154	CcSEcCtD
Cefadroxil—Diarrhoea—Everolimus—kidney cancer	0.000906	0.00153	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Sunitinib—kidney cancer	0.000904	0.00153	CcSEcCtD
Cefadroxil—Pruritus—Erlotinib—kidney cancer	0.000903	0.00153	CcSEcCtD
Cefadroxil—Tension—Paclitaxel—kidney cancer	0.000893	0.00151	CcSEcCtD
Cefadroxil—Agranulocytosis—Capecitabine—kidney cancer	0.000892	0.00151	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—kidney cancer	0.000889	0.0015	CcSEcCtD
Cefadroxil—Anaphylactic shock—Gemcitabine—kidney cancer	0.000887	0.0015	CcSEcCtD
Cefadroxil—Nervousness—Paclitaxel—kidney cancer	0.000884	0.00149	CcSEcCtD
Cefadroxil—Dizziness—Vinblastine—kidney cancer	0.000879	0.00149	CcSEcCtD
Cefadroxil—Dizziness—Everolimus—kidney cancer	0.000875	0.00148	CcSEcCtD
Cefadroxil—Muscle spasms—Paclitaxel—kidney cancer	0.000875	0.00148	CcSEcCtD
Cefadroxil—Abdominal pain—Sunitinib—kidney cancer	0.000874	0.00148	CcSEcCtD
Cefadroxil—Body temperature increased—Sunitinib—kidney cancer	0.000874	0.00148	CcSEcCtD
Cefadroxil—Diarrhoea—Erlotinib—kidney cancer	0.000874	0.00148	CcSEcCtD
Cefadroxil—Thrombocytopenia—Gemcitabine—kidney cancer	0.000868	0.00147	CcSEcCtD
Cefadroxil—Haemoglobin—Capecitabine—kidney cancer	0.000862	0.00146	CcSEcCtD
Cefadroxil—Haemorrhage—Capecitabine—kidney cancer	0.000858	0.00145	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000856	0.00145	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000852	0.00144	CcSEcCtD
Cefadroxil—Hypersensitivity—Sorafenib—kidney cancer	0.000846	0.00143	CcSEcCtD
Cefadroxil—Vomiting—Vinblastine—kidney cancer	0.000845	0.00143	CcSEcCtD
Cefadroxil—Dizziness—Erlotinib—kidney cancer	0.000844	0.00143	CcSEcCtD
Cefadroxil—Vomiting—Everolimus—kidney cancer	0.000841	0.00142	CcSEcCtD
Cefadroxil—Rash—Everolimus—kidney cancer	0.000834	0.00141	CcSEcCtD
Cefadroxil—Dermatitis—Everolimus—kidney cancer	0.000834	0.00141	CcSEcCtD
Cefadroxil—Headache—Vinblastine—kidney cancer	0.000832	0.00141	CcSEcCtD
Cefadroxil—Angioedema—Paclitaxel—kidney cancer	0.000831	0.00141	CcSEcCtD
Cefadroxil—Headache—Everolimus—kidney cancer	0.000829	0.0014	CcSEcCtD
Cefadroxil—Body temperature increased—Dactinomycin—kidney cancer	0.000827	0.0014	CcSEcCtD
Cefadroxil—Abdominal pain—Dactinomycin—kidney cancer	0.000827	0.0014	CcSEcCtD
Cefadroxil—Asthenia—Sorafenib—kidney cancer	0.000824	0.00139	CcSEcCtD
Cefadroxil—Vertigo—Paclitaxel—kidney cancer	0.000818	0.00138	CcSEcCtD
Cefadroxil—Hypersensitivity—Sunitinib—kidney cancer	0.000814	0.00138	CcSEcCtD
Cefadroxil—Pruritus—Sorafenib—kidney cancer	0.000813	0.00137	CcSEcCtD
Cefadroxil—Vomiting—Erlotinib—kidney cancer	0.000812	0.00137	CcSEcCtD
Cefadroxil—Erythema multiforme—Capecitabine—kidney cancer	0.000811	0.00137	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000808	0.00137	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Vincristine—kidney cancer	0.000807	0.00136	CcSEcCtD
Cefadroxil—Rash—Erlotinib—kidney cancer	0.000805	0.00136	CcSEcCtD
Cefadroxil—Dermatitis—Erlotinib—kidney cancer	0.000804	0.00136	CcSEcCtD
Cefadroxil—Headache—Erlotinib—kidney cancer	0.0008	0.00135	CcSEcCtD
Cefadroxil—Asthenia—Sunitinib—kidney cancer	0.000793	0.00134	CcSEcCtD
Cefadroxil—Nausea—Vinblastine—kidney cancer	0.000789	0.00133	CcSEcCtD
Cefadroxil—Somnolence—Gemcitabine—kidney cancer	0.000789	0.00133	CcSEcCtD
Cefadroxil—Convulsion—Paclitaxel—kidney cancer	0.000788	0.00133	CcSEcCtD
Cefadroxil—Nausea—Everolimus—kidney cancer	0.000786	0.00133	CcSEcCtD
Cefadroxil—Diarrhoea—Sorafenib—kidney cancer	0.000786	0.00133	CcSEcCtD
Cefadroxil—Pruritus—Sunitinib—kidney cancer	0.000782	0.00132	CcSEcCtD
Cefadroxil—Arthralgia—Paclitaxel—kidney cancer	0.000775	0.00131	CcSEcCtD
Cefadroxil—Hypersensitivity—Dactinomycin—kidney cancer	0.000771	0.0013	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000766	0.00129	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Vincristine—kidney cancer	0.000765	0.00129	CcSEcCtD
Cefadroxil—Dizziness—Sorafenib—kidney cancer	0.00076	0.00128	CcSEcCtD
Cefadroxil—Nausea—Erlotinib—kidney cancer	0.000759	0.00128	CcSEcCtD
Cefadroxil—Diarrhoea—Sunitinib—kidney cancer	0.000756	0.00128	CcSEcCtD
Cefadroxil—Asthenia—Dactinomycin—kidney cancer	0.000751	0.00127	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—kidney cancer	0.000749	0.00127	CcSEcCtD
Cefadroxil—Anaphylactic shock—Paclitaxel—kidney cancer	0.000743	0.00126	CcSEcCtD
Cefadroxil—Body temperature increased—Vincristine—kidney cancer	0.000739	0.00125	CcSEcCtD
Cefadroxil—Abdominal pain—Vincristine—kidney cancer	0.000739	0.00125	CcSEcCtD
Cefadroxil—Dizziness—Sunitinib—kidney cancer	0.000731	0.00124	CcSEcCtD
Cefadroxil—Vomiting—Sorafenib—kidney cancer	0.00073	0.00123	CcSEcCtD
Cefadroxil—Thrombocytopenia—Paclitaxel—kidney cancer	0.000727	0.00123	CcSEcCtD
Cefadroxil—Rash—Sorafenib—kidney cancer	0.000724	0.00122	CcSEcCtD
Cefadroxil—Dermatitis—Sorafenib—kidney cancer	0.000724	0.00122	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00072	0.00122	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00072	0.00122	CcSEcCtD
Cefadroxil—Headache—Sorafenib—kidney cancer	0.00072	0.00122	CcSEcCtD
Cefadroxil—Muscle spasms—Capecitabine—kidney cancer	0.000718	0.00121	CcSEcCtD
Cefadroxil—Diarrhoea—Dactinomycin—kidney cancer	0.000716	0.00121	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000705	0.00119	CcSEcCtD
Cefadroxil—Vomiting—Sunitinib—kidney cancer	0.000703	0.00119	CcSEcCtD
Cefadroxil—Body temperature increased—Gemcitabine—kidney cancer	0.000701	0.00119	CcSEcCtD
Cefadroxil—Rash—Sunitinib—kidney cancer	0.000697	0.00118	CcSEcCtD
Cefadroxil—Dermatitis—Sunitinib—kidney cancer	0.000696	0.00118	CcSEcCtD
Cefadroxil—Headache—Sunitinib—kidney cancer	0.000693	0.00117	CcSEcCtD
Cefadroxil—Hypersensitivity—Vincristine—kidney cancer	0.000689	0.00116	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—kidney cancer	0.000684	0.00116	CcSEcCtD
Cefadroxil—Nausea—Sorafenib—kidney cancer	0.000682	0.00115	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000677	0.00114	CcSEcCtD
Cefadroxil—Vertigo—Capecitabine—kidney cancer	0.000671	0.00113	CcSEcCtD
Cefadroxil—Asthenia—Vincristine—kidney cancer	0.000671	0.00113	CcSEcCtD
Cefadroxil—Vomiting—Dactinomycin—kidney cancer	0.000665	0.00112	CcSEcCtD
Cefadroxil—Somnolence—Paclitaxel—kidney cancer	0.00066	0.00112	CcSEcCtD
Cefadroxil—Rash—Dactinomycin—kidney cancer	0.00066	0.00112	CcSEcCtD
Cefadroxil—Nausea—Sunitinib—kidney cancer	0.000657	0.00111	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—kidney cancer	0.000656	0.00111	CcSEcCtD
Cefadroxil—Dyspepsia—Paclitaxel—kidney cancer	0.000654	0.00111	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—kidney cancer	0.000646	0.00109	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000641	0.00108	CcSEcCtD
Cefadroxil—Diarrhoea—Vincristine—kidney cancer	0.00064	0.00108	CcSEcCtD
Cefadroxil—Asthenia—Gemcitabine—kidney cancer	0.000636	0.00108	CcSEcCtD
Cefadroxil—Arthralgia—Capecitabine—kidney cancer	0.000636	0.00107	CcSEcCtD
Cefadroxil—Pruritus—Gemcitabine—kidney cancer	0.000628	0.00106	CcSEcCtD
Cefadroxil—Nausea—Dactinomycin—kidney cancer	0.000622	0.00105	CcSEcCtD
Cefadroxil—Dizziness—Vincristine—kidney cancer	0.000618	0.00105	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—kidney cancer	0.000616	0.00104	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000611	0.00103	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000607	0.00103	CcSEcCtD
Cefadroxil—Diarrhoea—Gemcitabine—kidney cancer	0.000607	0.00103	CcSEcCtD
Cefadroxil—Thrombocytopenia—Capecitabine—kidney cancer	0.000597	0.00101	CcSEcCtD
Cefadroxil—Vomiting—Vincristine—kidney cancer	0.000595	0.001	CcSEcCtD
Cefadroxil—Urticaria—Paclitaxel—kidney cancer	0.00059	0.000997	CcSEcCtD
Cefadroxil—Rash—Vincristine—kidney cancer	0.00059	0.000997	CcSEcCtD
Cefadroxil—Dermatitis—Vincristine—kidney cancer	0.000589	0.000996	CcSEcCtD
Cefadroxil—Abdominal pain—Paclitaxel—kidney cancer	0.000587	0.000992	CcSEcCtD
Cefadroxil—Body temperature increased—Paclitaxel—kidney cancer	0.000587	0.000992	CcSEcCtD
Cefadroxil—Headache—Vincristine—kidney cancer	0.000586	0.00099	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—kidney cancer	0.000575	0.000972	CcSEcCtD
Cefadroxil—Vomiting—Gemcitabine—kidney cancer	0.000564	0.000953	CcSEcCtD
Cefadroxil—Rash—Gemcitabine—kidney cancer	0.000559	0.000945	CcSEcCtD
Cefadroxil—Dermatitis—Gemcitabine—kidney cancer	0.000559	0.000945	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—kidney cancer	0.000556	0.000939	CcSEcCtD
Cefadroxil—Headache—Gemcitabine—kidney cancer	0.000556	0.000939	CcSEcCtD
Cefadroxil—Nausea—Vincristine—kidney cancer	0.000555	0.000939	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000555	0.000939	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—kidney cancer	0.000553	0.000935	CcSEcCtD
Cefadroxil—Hypersensitivity—Paclitaxel—kidney cancer	0.000547	0.000925	CcSEcCtD
Cefadroxil—Dyspepsia—Capecitabine—kidney cancer	0.000536	0.000907	CcSEcCtD
Cefadroxil—Asthenia—Paclitaxel—kidney cancer	0.000533	0.000901	CcSEcCtD
Cefadroxil—Nausea—Gemcitabine—kidney cancer	0.000527	0.000891	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000526	0.000889	CcSEcCtD
Cefadroxil—Pruritus—Paclitaxel—kidney cancer	0.000525	0.000888	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—kidney cancer	0.000523	0.000884	CcSEcCtD
Cefadroxil—Diarrhoea—Paclitaxel—kidney cancer	0.000508	0.000859	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Capecitabine—kidney cancer	0.000498	0.000842	CcSEcCtD
Cefadroxil—Dizziness—Paclitaxel—kidney cancer	0.000491	0.00083	CcSEcCtD
Cefadroxil—Urticaria—Capecitabine—kidney cancer	0.000484	0.000818	CcSEcCtD
Cefadroxil—Abdominal pain—Capecitabine—kidney cancer	0.000482	0.000814	CcSEcCtD
Cefadroxil—Body temperature increased—Capecitabine—kidney cancer	0.000482	0.000814	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—kidney cancer	0.000472	0.000798	CcSEcCtD
Cefadroxil—Vomiting—Paclitaxel—kidney cancer	0.000472	0.000798	CcSEcCtD
Cefadroxil—Rash—Paclitaxel—kidney cancer	0.000468	0.000792	CcSEcCtD
Cefadroxil—Dermatitis—Paclitaxel—kidney cancer	0.000468	0.000791	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—kidney cancer	0.000468	0.00079	CcSEcCtD
Cefadroxil—Headache—Paclitaxel—kidney cancer	0.000465	0.000786	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—kidney cancer	0.000463	0.000782	CcSEcCtD
Cefadroxil—Hypersensitivity—Capecitabine—kidney cancer	0.000449	0.000759	CcSEcCtD
Cefadroxil—Nausea—Paclitaxel—kidney cancer	0.000441	0.000746	CcSEcCtD
Cefadroxil—Asthenia—Capecitabine—kidney cancer	0.000437	0.000739	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—kidney cancer	0.000432	0.000731	CcSEcCtD
Cefadroxil—Pruritus—Capecitabine—kidney cancer	0.000431	0.000729	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—kidney cancer	0.000417	0.000705	CcSEcCtD
Cefadroxil—Diarrhoea—Capecitabine—kidney cancer	0.000417	0.000705	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—kidney cancer	0.00041	0.000693	CcSEcCtD
Cefadroxil—Dizziness—Capecitabine—kidney cancer	0.000403	0.000681	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—kidney cancer	0.000393	0.000664	CcSEcCtD
Cefadroxil—Vomiting—Capecitabine—kidney cancer	0.000387	0.000655	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—kidney cancer	0.000385	0.00065	CcSEcCtD
Cefadroxil—Rash—Capecitabine—kidney cancer	0.000384	0.00065	CcSEcCtD
Cefadroxil—Dermatitis—Capecitabine—kidney cancer	0.000384	0.000649	CcSEcCtD
Cefadroxil—Headache—Capecitabine—kidney cancer	0.000382	0.000645	CcSEcCtD
Cefadroxil—Nausea—Capecitabine—kidney cancer	0.000362	0.000612	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000358	0.000605	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—kidney cancer	0.000349	0.00059	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—kidney cancer	0.000346	0.000585	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000339	0.000573	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000321	0.000543	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—kidney cancer	0.000312	0.000528	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—kidney cancer	0.000311	0.000525	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—kidney cancer	0.000311	0.000525	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—kidney cancer	0.000289	0.000489	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—kidney cancer	0.000282	0.000476	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—kidney cancer	0.000278	0.00047	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—kidney cancer	0.000269	0.000454	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—kidney cancer	0.00026	0.000439	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—kidney cancer	0.00025	0.000422	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—kidney cancer	0.000248	0.000419	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—kidney cancer	0.000247	0.000418	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—kidney cancer	0.000246	0.000416	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—kidney cancer	0.000233	0.000394	CcSEcCtD
